Results 271 to 280 of about 1,816,357 (289)
Some of the next articles are maybe not open access.

IL-12-Based therapy of malignancies

Drugs of Today, 2001
Interleukin-12 (IL-12) is an important molecule that triggers the activation of natural killer (NK) cells and T-cells, the development of T helper type 1 (Th1) cells and the expression of antiangiogenic genes. Novel methods for IL-12 delivery include cell-based ex vivo gene therapy, viral vector-based gene therapy and DNA plasmid-based nonviral gene ...
openaire   +2 more sources

The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases

Medical Microbiology and Immunology, 2004
Appropriate induction of a Th1 immune response is required for effective antimicrobial immunity. However, dysregulated Th1 immune responses after infection may also lead to immunopathology. Thus, cell-mediated immune responses have to be tightly regulated. Upon infection, the production of interleukin (IL)-12, a heterodimeric cytokine composed of a p35
openaire   +2 more sources

IL-12 in Autoimmunity

Clinical Immunology and Immunopathology, 1998
openaire   +2 more sources

IL-12

Immunology Today, 1999
openaire   +1 more source

Effects of IL‐12 and Antibodies to IL‐12 on Established Granulomatous Colitis in Mice

Annals of the New York Academy of Sciences, 1996
M F, Neurath   +4 more
openaire   +2 more sources

Mouse interleukin-12 (IL-12) p40 homodimer:

European journal of immunology, 1995
Interleukin-12 (IL-12) is a cytokine that has regulatory effects on T and natural killer (NK) cells and is composed of two disulfide-bonded subunits, p40 and p35. It was recently reported that supernatants from cultures of mouse IL-12 (moIL-12) p40-transfected COS cells could inhibit IL-12-dependent responses in vitro (Mattner, F., et al., Eur.
Gillessen Sommer, Silke   +9 more
openaire   +1 more source

IL-12

2001
Katherine A. Fitzgerald   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy